Routine noninvasive prenatal screening for fetal RHD in plasma of RhD‐negative pregnant women—2 years of screening experience from Denmark
- 24 May 2014
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 34 (10) , 1000-1005
Abstract
Objective: Prenatal and postnatal RhD prophylaxis reduces the risk of RhD immunization in pregnancies of RhD‐negative women. Based on the result from prenatal screening for the fetal RHD gene, prenatal RhD prophylaxis in Denmark is targeted to RhD‐negative women who carry an RhD‐positive fetus. Here, we present a 2‐year evaluation of a nationwide prenatal RHD screening.Methods: Blood samples were drawn from RhD‐negative women in gestational week 25. DNA was extracted from maternal plasma and analyzed for the RHD gene. The prenatal RHD results were compared with the serological typing of newborns in 12,668 pregnancies. Early compliance was assessed for 690 pregnancies.Results: The sensitivity for the detection of fetal RHD was 99.9% (95% CI: 99.7–99.9%). Unnecessary recommendation of prenatal RhD prophylaxis was avoided in 97.3% of the women carrying an RhD‐negative fetus. Fetuses that were seropositive for RhD were not detected in 11 pregnancies (0.087%). The sample uptake percentage was 84.2%, and the compliance for prenatal anti‐D administration was 93.2%.Conclusion: The high sensitivity, maintained over 2 years, underlines the reliability of routine prenatal fetal RHD screening in RhD‐negative pregnant women, specifically at 25 weeks of gestation. The remaining challenges are logistical and are related to program compliance. © 2014 John Wiley & Sons, Ltd.Keywords
This publication has 35 references indexed in Scilit:
- Pre-Analytical Conditions in Non-Invasive Prenatal Testing of Cell-Free Fetal RHDPLOS ONE, 2013
- Targeted Routine Antenatal Anti-D Prophylaxis in the Prevention of RhD Immunisation - Outcome of a New Antenatal Screening and Prevention ProgramPLOS ONE, 2013
- Prenatal screeningISBT Science Series, 2013
- Cell‐free fetal DNA in specimen from pregnant women is stable up to 5 daysPrenatal Diagnosis, 2011
- Report of the first nationally implemented clinical routine screening for fetal RHD in D− pregnant women to ascertain the requirement for antenatal RhD prophylaxisTransfusion, 2011
- An international reference reagent for the detection of RHD and SRY DNA in plasmaVox Sanguinis, 2011
- Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experienceBJOG: An International Journal of Obstetrics & Gynaecology, 2011
- Prenatal RhD Testing: A Review of Studies Published from 2006 to 2008Transfusion Medicine and Hemotherapy, 2009
- Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility studyBMJ, 2008
- Quantitative Analysis of Fetal DNA in Maternal Plasma and Serum: Implications for Noninvasive Prenatal DiagnosisThe American Journal of Human Genetics, 1998